Literature DB >> 26350132

Antimicrobial Peptide Conformation as a Structural Determinant of Omptin Protease Specificity.

John R Brannon1, Jenny-Lee Thomassin1, Samantha Gruenheid2, Hervé Le Moual3.   

Abstract

UNLABELLED: Bacterial proteases contribute to virulence by cleaving host or bacterial proteins to promote survival and dissemination. Omptins are a family of proteases embedded in the outer membrane of Gram-negative bacteria that cleave various substrates, including host antimicrobial peptides, with a preference for cleaving at dibasic motifs. OmpT, the enterohemorrhagic Escherichia coli (EHEC) omptin, cleaves and inactivates the human cathelicidin LL-37. Similarly, the omptin CroP, found in the murine pathogen Citrobacter rodentium, which is used as a surrogate model to study human-restricted EHEC, cleaves the murine cathelicidin-related antimicrobial peptide (CRAMP). Here, we compared the abilities of OmpT and CroP to cleave LL-37 and CRAMP. EHEC OmpT degraded LL-37 and CRAMP at similar rates. In contrast, C. rodentium CroP cleaved CRAMP more rapidly than LL-37. The different cleavage rates of LL-37 and CRAMP were independent of the bacterial background and substrate sequence specificity, as OmpT and CroP have the same preference for cleaving at dibasic sites. Importantly, LL-37 was α-helical and CRAMP was unstructured under our experimental conditions. By altering the α-helicity of LL-37 and CRAMP, we found that decreasing LL-37 α-helicity increased its rate of cleavage by CroP. Conversely, increasing CRAMP α-helicity decreased its cleavage rate. This structural basis for CroP substrate specificity highlights differences between the closely related omptins of C. rodentium and E. coli. In agreement with previous studies, this difference in CroP and OmpT substrate specificity suggests that omptins evolved in response to the substrates present in their host microenvironments. IMPORTANCE: Omptins are recognized as key virulence factors for various Gram-negative pathogens. Their localization to the outer membrane, their active site facing the extracellular environment, and their unique catalytic mechanism make them attractive targets for novel therapeutic strategies. Gaining insights into similarities and variations between the different omptin active sites and subsequent substrate specificities will be critical to develop inhibitors that can target multiple omptins. Here, we describe subtle differences between the substrate specificities of two closely related omptins, CroP and OmpT. This is the first reported example of substrate conformation acting as a structural determinant for omptin activity between OmpT-like proteases.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26350132      PMCID: PMC4621091          DOI: 10.1128/JB.00469-15

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  55 in total

1.  The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides.

Authors:  Robert A Dorschner; Belen Lopez-Garcia; Andreas Peschel; Dirk Kraus; Kazuya Morikawa; Victor Nizet; Richard L Gallo
Journal:  FASEB J       Date:  2006-01       Impact factor: 5.191

Review 2.  Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?

Authors:  Kim A Brogden
Journal:  Nat Rev Microbiol       Date:  2005-03       Impact factor: 60.633

Review 3.  Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies.

Authors:  Robert E W Hancock; Hans-Georg Sahl
Journal:  Nat Biotechnol       Date:  2006-12       Impact factor: 54.908

4.  A plasminogen-activating protease specifically controls the development of primary pneumonic plague.

Authors:  Wyndham W Lathem; Paul A Price; Virginia L Miller; William E Goldman
Journal:  Science       Date:  2007-01-26       Impact factor: 47.728

Review 5.  Citrobacter rodentium of mice and man.

Authors:  Rosanna Mundy; Thomas T MacDonald; Gordon Dougan; Gad Frankel; Siouxsie Wiles
Journal:  Cell Microbiol       Date:  2005-12       Impact factor: 3.715

6.  Why is the Arg5-Glu13 salt bridge conserved in mammalian alpha-defensins?

Authors:  Zhibin Wu; Xiangqun Li; Erik de Leeuw; Bryan Ericksen; Wuyuan Lu
Journal:  J Biol Chem       Date:  2005-10-24       Impact factor: 5.157

7.  Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases.

Authors:  Magdalena Sieprawska-Lupa; Piotr Mydel; Katarzyna Krawczyk; Kinga Wójcik; Magdalena Puklo; Boguslaw Lupa; Piotr Suder; Jerzy Silberring; Matthew Reed; Jan Pohl; William Shafer; Fionnuala McAleese; Timothy Foster; Jim Travis; Jan Potempa
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

8.  Substrate specificity of the Escherichia coli outer membrane protease OmpP.

Authors:  Bum-Yeol Hwang; Navin Varadarajan; Haixin Li; Sarah Rodriguez; Brent L Iverson; George Georgiou
Journal:  J Bacteriol       Date:  2006-11-03       Impact factor: 3.490

9.  The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface.

Authors:  R Bals; X Wang; M Zasloff; J M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

10.  Host susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentium.

Authors:  Bruce A Vallance; Wanyin Deng; Kevan Jacobson; B Brett Finlay
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

View more
  3 in total

1.  Targeting cancer-specific glycans by cyclic peptide lectinomimics.

Authors:  Maria C Rodriguez; Austin B Yongye; Mihael Cudic; Karina Martinez Mayorga; Enbo Liu; Barbara M Mueller; Jon Ainsley; Tatyana Karabencheva-Christova; Christo Z Christov; Mare Cudic; Predrag Cudic
Journal:  Amino Acids       Date:  2017-09-11       Impact factor: 3.520

Review 2.  The arsenal of pathogens and antivirulence therapeutic strategies for disarming them.

Authors:  John R Brannon; Maria Hadjifrangiskou
Journal:  Drug Des Devel Ther       Date:  2016-05-27       Impact factor: 4.162

3.  Identification and characterization of OmpT-like proteases in uropathogenic Escherichia coli clinical isolates.

Authors:  Isabelle Desloges; James A Taylor; Jean-Mathieu Leclerc; John R Brannon; Andrea Portt; John D Spencer; Ken Dewar; Gregory T Marczynski; Amee Manges; Samantha Gruenheid; Hervé Le Moual; Jenny-Lee Thomassin
Journal:  Microbiologyopen       Date:  2019-09-08       Impact factor: 3.904

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.